USPTO 2015–2025 USPTO PatentsView Foreign Corporation

DIO Corporation

USPTO PatentsView assignee record - 29 granted patents across 10 technology areas, recorded in grant years 2017–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61C (DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE).

29
Total patents granted
10
CPC technology areas
6.8
Avg claims per patent
+525%
5-year grant velocity

The verdict

According to USPTO PatentsView, DIO ranks #10,595 of 50,000 tracked US assignees by granted-patent volume, with 29 patents across 10 technology areas.

#10,595
of 50,000 US assignees by volume
Top 19%
by Innovation Score (47.0/100)
6.8
avg claims per patent
+525%
grant velocity, last 5 yrs

Portfolio overview

DIO Corporation has been granted 29 US utility patents between 2017 and 2024, placing DIO Corporation at #10,595 of 50,000 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 6.8 claims per patent with primary concentration in A61C (DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE). As a Foreign Corporation, DIO Corporation is one of the more focused assignees in the PatentsView dataset. By volume, DIO sits between Control Components, Inc. (29 patents, rank #10,587) and Depuy International Limited (29 patents, rank #10,595) - the closest US assignees by grant volume. The composite Innovation Score of 47.0/100 blends portfolio volume, grant velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Grant cadence records the difference between two grant-year windows. Between 2020 and 2024 the company received 25 grants, compared with 4 in the 2015–2019 window, a +525% shift in five-year grant velocity. Both windows cover five complete grant years; the latest PatentsView year is a partial release and is excluded from this comparison, though it still appears in the yearly table and chart below. Grant timing can lag the related application by years, so this comparison does not establish current R&D spending, strategic intent, or a company’s application activity. The Foreign Corporation classification provides context for the assignee record, not a conclusion about its business strategy.

Claim depth and technology breadth describe this aggregate record. DIO Corporation's 6.8 average claims per patent is an average count, not a measure of claim scope, legal strength, enforceability, or design-around risk. The record spans 10 CPC subclasses. Combined with portfolio volume, these figures let readers compare the documented grant records of assignees in similar technology classes.

Who files at DIO's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows DIO holds 29 patents at rank #10,591, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near DIO

By rank, the assignees closest to #10,591 in granted patent volume.

Leaders in A61C (Dentistry)

Other assignees with the most granted patents in DIO's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for DIO, neither rank-band nor same-CPC leaders (those blocks stay above).

Similar innovation score

Nearest assignees by Innovation Score (47 here).

DIO's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

47 Top 19% higher than 81% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

051015 201720202021202220232024 6
USPTO utility patent grants by year · 2017–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
DIO Corporation patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 4 13.8%
2020 3 10.3%
2021 1 3.4%
2022 11 37.9%
2023 4 13.8%
2024 6 20.7%

Grant record at a glance

Portfolio Volume 29 grants
CPC subclasses 10
Avg. claims / grant 6.8
Velocity +525%

Historical grant data only; it does not rate legal strength or current strategy.

Where it ranks

Overall rank by patents

#10,595

of 50,000 tracked assignees

Innovation Score

47.0 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

Where does DIO Corporation rank among US patent assignees?
According to USPTO PatentsView (2015–2025 granted utility patents), DIO Corporation ranks #10,595 of 50,000 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.
How many patents does DIO Corporation hold?
DIO Corporation holds 29 US utility patents granted between 2017 and 2024, spanning 10 technology areas.
What is DIO Corporation's Innovation Score?
DIO Corporation has an Innovation Score of 47.0 out of 100 (top 19% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does DIO Corporation focus on?
DIO Corporation's top technology area is A61C (DENTISTRY; APPARATUS OR METHODS FOR ORAL OR DENTAL HYGIENE) with 19 patents. Grants appear in 10 CPC subclasses total.
Is DIO Corporation's patent grant rate increasing or decreasing?
DIO Corporation's recent grant velocity is +525% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.
What does claim depth mean for DIO Corporation's patents?
DIO Corporation's patents average 6.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.
How is the DIO Corporation patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

DIO's 29 grants land it in the top 19% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - DIO ranks #10,595 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in A61C - see who else leads that technology area. A61C leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.